10.11.2014 Views

Medical and Biological Sciences XXVI/2 - Collegium Medicum ...

Medical and Biological Sciences XXVI/2 - Collegium Medicum ...

Medical and Biological Sciences XXVI/2 - Collegium Medicum ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

8<br />

Julia Feit et. al.<br />

individuals, who are not carriers of the virus, does not<br />

differ statistically significantly from drug addicts who<br />

are HIV positive.<br />

putamen) <strong>and</strong> functionally being a central structure of<br />

the limbic system <strong>and</strong> reward system [19].<br />

However, increasing the motor performance of<br />

HIV(+) individuals may be influenced by many<br />

pharmacokinetic factors.<br />

Antiviral medicines often interact with methadone<br />

due to the complex metabolism which may lead to<br />

intensified adverse events including reduction or<br />

potentiating of the effectiveness of methadone.<br />

The pharmacokinetic properties of the same drug<br />

can vary considerably between patients due to genetic<br />

factors or comorbidities including liver damage<br />

associated with HCV <strong>and</strong> HBV infection. Those are<br />

very common in this group of patients. All of these<br />

medications interact with methadone <strong>and</strong> antiviral<br />

drugs [20, 21, 22, 23].<br />

Fig. 3. The comparison of execution time TMT A test before<br />

<strong>and</strong> after the administration of a single dose of<br />

methadone in the group of HIV(+)<br />

Ryc. 3. Porównanie czasu wykonania testu TMT A przed i po<br />

podaniu metadonu w grupie osób HIV(+)<br />

DISCUSSION<br />

The study aimed to verify the effect of a single dose<br />

of methadone on the motor skills of HIV(+) persons<br />

addicted to opioids in comparison to HIV(-) ones. In<br />

addition, the TMT test examined whether its values<br />

depend on the dose of methadone taken <strong>and</strong> the<br />

duration of treatment.<br />

It was found that there are statistically significant<br />

differences both in the speed of TMT A test<br />

completion <strong>and</strong> in the duration of methadone<br />

treatment.<br />

However, this does not mean that there is<br />

a correlation between these results, because the<br />

duration of the treatment may be associated with a<br />

virus carrier status, which is associated with the risk of<br />

loss of life, <strong>and</strong> what therefore motivates people in this<br />

group for a systematic substitution therapy.<br />

The time of completion of the TMT A test in<br />

subjects from both groups may be related to the<br />

influence of psychoactive substances in the nervous<br />

centers [18,9]. It was found that in people addicted to<br />

psychoactive substances, structural <strong>and</strong> functional<br />

changes take place in the ventral striatum. The major<br />

part of which is the nucleus accumbens anatomically a<br />

part of the striatum (including caudate nucleus <strong>and</strong><br />

CONCLUSION<br />

Based on the analysis of the test results in opioid<br />

addicted subjects, who are participants of the<br />

methadone program, before <strong>and</strong> after the<br />

administration of a therapeutic dose of methadone, it<br />

can be concluded that the adoption of a therapeutic<br />

dose of methadone statistically significantly increases<br />

psychomotor performance.<br />

The size of methadone dose does not influence the<br />

study results. The duration of treatment, which is<br />

statistically significantly longer in HIV(+) individuals,<br />

can be determined by a life-threatening risk in this<br />

group. A single dose of methadone statistically<br />

significantly affects motor functions of HIV(+)<br />

subjects.<br />

REFERENCES<br />

1. Anthony J. C., Warner L., Kessler R. Comparative<br />

epidemiology of dependence on tabacco, alcohol,<br />

controlled substances <strong>and</strong> inhalants: Basic findings<br />

from the National Comorbidity Survey. Experimental<br />

<strong>and</strong> Clinical Psychopharmacology 1994, 2(3), 244-68.<br />

2. Teesson M., Hall W., Degenhardt L. Uzależnienia -<br />

Modele kliniczne i techniki terapeutyczne. GWP,<br />

Gdańsk, 2005.<br />

3. Connor M., Christie MD. Opioid receptor signalling<br />

mechanisms. Clin.Exp. Pharmacol. Physiol. 1999, 26,<br />

493-9.<br />

4. Law P.Y., Wong Y.H., Loh H.H. Molecular<br />

mechanisms <strong>and</strong> regulationof opioid receptor signaling.<br />

Annu. Rev. Pharmacol. Toxicol. 2000, 40, 389–430.<br />

5. Ross S., Peselow E. The neurobiology of addictive<br />

disorders. Clin Neuropharmacol. 2009, 269-76.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!